Abstract:Objective To summarize the clinical experiences of video-assisted thoracoscopic surgery(VATS) lobectomy performed on a series of 300 consecutive patients,and report the results of a 3-year follow-up.Methods We retrospectively analyzed the clinical data of 300 consecutive patients who underwent VATS lobectomy from September 2006 to December 2009 in the Department of Thoracic Surgery,People's Hospital of Peking University.Of the 300 patients,there were 159 males and 141 females with the age ranged from 18 to 86 years(58.30±13.90 years).Preoperative diagnosis showed that there were 266 patients of mass in the lung,22 of bronchiectasis,5 of cyst/abscess in the lung,3 of pulmonary sequestration,2 of fungus infection,and 2 of pneumothorax.We assessed the peri-operative variables by standard descriptive statistics and estimated the 3-year survival rate by Kaplan-Meier analyses.Results Sixty-six patients were diagnosed to have benign diseases and 234 patients were with malignancies.A percentage of 81.82%(54/66) of the benign patients had infectious diseases,and the majority of the malignancies was non-small cell lung cancer(213 patients),especially adenocarcinomas which comprised 73.08%(171/234) of all the malignancies.A total of 273 patients accomplished VATS lobectomy,of whom 27 patients required conversion to thoracotomy at a conversion rate of 9.00%(27/300).In the VATS lobectomy accomplished group,the mean operation time was 3.17±0.88 h,and the blood loss was 225.70±195.20 ml.Benign surgery took significantly less time(t=2.280,P=0.0032) and had shorter drainage time(t=1.392,P=0.0304) than those of malignancies.Dense adhesions between lymph nodes and blood vessels was the primary reason for conversion to thoracotomy in 17 patients at a percentage of 62.96%(17/27).Bleeding was the second reason for conversion in 5 patients at a percentage of 18.52%.The patients in the upper lobe lobectomy group showed significantly higher risk of conversion compared with those in the non-upper lobe surgery group(χ2=6.131,P=0.013),while gender(χ2=1.182,P=0.277),pathology(χ2=0.210,P=0.647) and the tumor located in left or right side(χ2=2.933,P=0.087) didn't influence the risk of conversion.The result of the 3-year follow-up showed that there was no reoccurrence of symptoms in patients with benign diseases;Non-small cell lung cancer patients had a 3-year survival rate of 0.87 with the 95% confidence interval(CI) from 0.77 to 0.96,and pathologic stage I patients at 0.91 with the 95%CI from 0.85 to 0.98.Conclusion VATS lobectomy is safe and effective.This research shows that domestic technologies of VATS lobectomy and its mid-term results have reached the international standard.

Quality of Life after Lobectomy for Early Stage Non-small Cell Lung Cancer——Video-assisted Thoracoscopic Surgery Versus Minimal Incision Thoracotomy

Comparison of Long-Term Clinical Efficacy of Patients with Non-Small Cell Lung Cancer Between Video-Assisted Minithoracotomy and Open Lobectomy

Perioperative Comparison of Video-Assisted Thoracic Surgery and Open Lobectomy for Pt1-Stage Non-Small Cell Lung Cancer Patients in China: a Multi-Center Propensity Score-Matched Analysis.

Lobectomy by video-assisted thoracoscopic surgery versus thoracotomy for clinical stage Ⅰ / Ⅱ non-small cell lung cancer: a multi-center comparative study

Video-assisted Thoracoscopic Surgery Lobectomy: a Series of Consecutive 300 Patients and a 3-year Follow-up

Video-assisted thoracoscopic surgery and thoracotomy during lobectomy for clinical stage I non-small-cell lung cancer have equivalent oncological outcomes: A single-center experience of 212 consecutive resections.

linical Outcome of Complete Video-assisted Thoracoscopic Surgery Lobectomy for Patients with Early-stage Non-small Cell Lung Cancer

Comparing the Efficacy of Video-Assisted Thoracoscopic Surgery and Open Thoracotomy in Sleeve Lobectomy for the Treatment of Central-Type Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Comparison of the Short-Term Quality of Life in Patients with Esophageal Cancer after Subtotal Esophagectomy Via Video-Assisted Thoracoscopic or Open Surgery

The Early Outcome of Video-Assisted Thoracic Surgery Lobectomy for Primary Lung Carcinoma

New approaches to acute lymphoblastic leukemia in adults: where do we go?

Video Assisted Thoracic Surgery Vs. Thoracotomy for Locally Advanced Lung Squamous Cell Carcinoma after Neoadjuvant Chemotherapy

Is Video-Assisted Thoracic Surgery Lobectomy Better Than Thoracotomy for Early-Stage Non-Small-cell Lung Cancer? A Systematic Review and Meta-Analysis.

Comparison of the perioperative effect of lobectomy between totally video-assisted thoracoscopic surgery and traditional open surgery on non-small cell lung cancer

Poor preoperative quality of life predicts prolonged hospital stay after VATS lobectomy for lung cancer

Video-Assisted Thoracoscopic Surgery Lobectomy for Lung Cancer: The Learning Curve

Comparison of Video-assisted Thoracoscopic with Open Dissection of Systematic Mediastinal Lymph Nodes for Clinical Stage Ⅰ Non-Small Cell Lung Cancer

[Cytokine Responses after Lobectomy for Early Non-Small Cell Lung Cancer: a Prospective Randomized Comparison of Video-Assisted Thoracic Surgery and Open Thoracotomy].

Comparison between video-assisted thoracic surgery (VATS) and traditional open surgery on lobectomy for non-small cell lung carcinoma

Long-term outcomes of video-assisted thoracoscopic surgery lobectomy vs. thoracotomy lobectomy for stage IA non-small cell lung cancer

Severe Intraoperative Complications During VATS Lobectomy Compared with Thoracotomy Lobectomy for Early Stage Non-Small Cell Lung Cancer.